MAPT and Alzheimer disease: Recent research indicates that phosphorylation at Thr‐231 induces the conformational alteration of the Tau protein, leading to a neurotoxic conformation known as cis p‐Tau, which is thought to contribute to the early stages of diverse neurodegenerative disorders, including AD.